These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30442505)

  • 21. Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
    Kragler A; Höfner G; Wanner KT
    Eur J Med Chem; 2008 Nov; 43(11):2404-11. PubMed ID: 18395300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
    Zaręba P; Sałat K; Höfner GC; Łątka K; Bajda M; Latacz G; Kotniewicz K; Rapacz A; Podkowa A; Maj M; Jóźwiak K; Filipek B; Wanner KT; Malawska B; Kulig K
    Eur J Med Chem; 2021 Oct; 221():113512. PubMed ID: 34015586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
    Steffan T; Renukappa-Gutke T; Höfner G; Wanner KT
    Bioorg Med Chem; 2015 Mar; 23(6):1284-306. PubMed ID: 25698617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
    Kowalczyk P; Sałat K; Höfner GC; Guzior N; Filipek B; Wanner KT; Kulig K
    Bioorg Med Chem; 2013 Sep; 21(17):5154-67. PubMed ID: 23859778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syntheses and GABA uptake properties of 6-ether- and 6-enol ether-substituted nipecotic acids.
    N'Goka V; Bissantz C; Bisel P; Stenbøl TB; Krogsgaard-Larsen P; Schlewer G
    Eur J Med Chem; 2004 Jul; 39(7):633-8. PubMed ID: 15236844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA-transporter.
    Thomsen C; Sørensen PO; Egebjerg J
    Br J Pharmacol; 1997 Mar; 120(6):983-5. PubMed ID: 9134205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of New Photoswitchable Azobenzene Based γ-Aminobutyric Acid (GABA) Uptake Inhibitors with Distinctly Enhanced Potency upon Photoactivation.
    Lutz T; Wein T; Höfner G; Pabel J; Eder M; Dine J; Wanner KT
    J Med Chem; 2018 Jul; 61(14):6211-6235. PubMed ID: 29924931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate.
    Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ
    J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives.
    Andersen KE; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
    Bioorg Med Chem; 2001 Nov; 9(11):2773-85. PubMed ID: 11597457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure activity relationship of selective GABA uptake inhibitors.
    Vogensen SB; Jørgensen L; Madsen KK; Jurik A; Borkar N; Rosatelli E; Nielsen B; Ecker GF; Schousboe A; Clausen RP
    Bioorg Med Chem; 2015 May; 23(10):2480-8. PubMed ID: 25882526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA uptake inhibitors containing mono- and diarylmethoxyalkyl N-substituents.
    Falch E; Krogsgaard-Larsen P
    Drug Des Deliv; 1989 May; 4(3):205-15. PubMed ID: 2535204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity studies on the inhibition of gamma-aminobutyric acid uptake in brain slices by compounds related to nipecotic acid.
    Wood JD; Tsui D; Phillis JW
    Can J Physiol Pharmacol; 1979 Jun; 57(6):581-5. PubMed ID: 226252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake.
    Pavia MR; Lobbestael SJ; Nugiel D; Mayhugh DR; Gregor VE; Taylor CP; Schwarz RD; Brahce L; Vartanian MG
    J Med Chem; 1992 Oct; 35(22):4238-48. PubMed ID: 1433224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and GABA uptake inhibitory properties of 6-aryl iminoxymethyl substituted nipecotic acids.
    N'goka V; Stenbøl TB; Krogsgaard-Larsen P; Schlewer G
    Eur J Med Chem; 2004 Oct; 39(10):889-95. PubMed ID: 15464623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.
    Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO
    J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I).
    Zheng J; Wen R; Luo X; Lin G; Zhang J; Xu L; Guo L; Jiang H
    Bioorg Med Chem Lett; 2006 Jan; 16(1):225-7. PubMed ID: 16246548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nipecotic acid as potential lead molecule for the development of GABA uptake inhibitors; structural insights and design strategies.
    Singh K; Kumar P; Bhatia R; Mehta V; Kumar B; Akhtar MJ
    Eur J Med Chem; 2022 Apr; 234():114269. PubMed ID: 35306287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and pharmacological evaluation of new 4,4-diphenylbut-3-enyl derivatives of 4-hydroxybutanamides as GABA uptake inhibitors.
    Kowalczyk P; Höfner G; Wanner KT; Kulig K
    Acta Pol Pharm; 2012; 69(1):157-60. PubMed ID: 22574521
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
    Hack S; Wörlein B; Höfner G; Pabel J; Wanner KT
    Eur J Med Chem; 2011 May; 46(5):1483-98. PubMed ID: 21353350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
    Zaręba P; Gryzło B; Malawska K; Sałat K; Höfner GC; Nowaczyk A; Fijałkowski Ł; Rapacz A; Podkowa A; Furgała A; Żmudzki P; Wanner KT; Malawska B; Kulig K
    Eur J Med Chem; 2020 Feb; 188():111920. PubMed ID: 31901745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.